We are live on ! Find out more
CORT icon

Corcept Therapeutics

135 hedge funds and large institutions have $664M invested in Corcept Therapeutics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 37 increasing their positions, 52 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

779% more call options, than puts

Call options by funds: $1.97M | Put options by funds: $224K

71% more capital invested

Capital invested by funds: $387M → $664M (+$277M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

5.64% more ownership

Funds ownership: 48.05%53.69% (+5.6%)

0% more funds holding

Funds holding: 135135 (0)

29% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 52

Holders
135
Holders Change
Holders Change %
0%
% of All Funds
3.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
28
Increased
37
Reduced
52
Closed
22
Calls
$1.97M
Puts
$224K
Net Calls
+$1.75M
Net Calls Change
+$858K
Name Holding Trade Value Shares
Change
Change in
Stake
CF
151
Corrigan Financial
Rhode Island
-$113K -15,528 Closed
SCA
152
Secor Capital Advisors
New York
-$107K -14,784 Closed
HSBC Holdings
153
HSBC Holdings
United Kingdom
-$93K -12,868 Closed
ProShare Advisors
154
ProShare Advisors
Maryland
-$87K -11,999 Closed
SB
155
Suntrust Banks
Georgia
-$85K -11,837 Closed
Balyasny Asset Management
156
Balyasny Asset Management
Illinois
-$85K -11,704 Closed
SCM
157
Sitrin Capital Management
California
-$73K -10,000 Closed